Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22440408 | 0.89 | THRB (0.57) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL28619494 | 0.86 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL10426403 | 0.86 | THRB (0.57) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL587661 | 0.86 | THRB (0.57) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL2453478 | 0.86 | THRB (0.57) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL15636 | 0.85 | THRB (0.74) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL6142874 | 0.85 | THRB (0.74) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL6695792 | 0.84 | THRB (0.55) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL75014 | 0.84 | THRB (0.55) | THRBTSHRALDH1A1TDP1POLB | |
| Ethylene SCHEMBL955493 | 0.82 | THRB (0.71) | THRBTSHRALDH1A1TDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4380494-A1 | COMPOSITION FOR ISOLATING TISSUE | Solventum Intellectual Properties Company (US) | 2024-06-12 | — | — | EP | disclosed |
| US-11597830-B2 | Radiation curable composition for additive manufacturing processes | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-03-07 | — | — | US | disclosed |
| WO-2023012556-A1 | COMPOSITION FOR ISOLATING TISSUE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-02-09 | — | — | WO | disclosed |
| EP-3641720-B1 | RADIATION CURABLE COMPOSITION FOR ADDITIVE MANUFACTURING PROCESSES | 3M INNOVATIVE PROPERTIES CO (US) | 2022-06-29 | — | — | EP | disclosed |
| US-20200131356-A1 | RADIATION CURABLE COMPOSITION FOR ADDITIVE MANUFACTURING PROCESSES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2020-04-30 | — | — | US | disclosed |
| EP-3641720-A1 | RADIATION CURABLE COMPOSITION FOR ADDITIVE MANUFACTURING PROCESSES | 3M Innovative Properties Company (US) | 2020-04-29 | — | — | EP | disclosed |
| WO-2018234898-A1 | RADIATION CURABLE COMPOSITION FOR ADDITIVE MANUFACTURING PROCESSES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-12-27 | — | — | WO | disclosed |
| US-5326346-A | Light-cured urethane dimethacrylate ocular prosthesis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-07-05 | — | — | US | disclosed |
| EP-0301516-B1 | DENTAL ADHESIVE COMPOSITION | MITSUBISHI RAYON CO., LTD. (JP) | 1992-09-23 | — | — | EP | disclosed |
| US-4968725-A | BONDING RESTORATIVE MATERIAL TO DENTIN WITHOUT PREETCHING | MITSUBISHI RAYON CO., LTD. (JP) | 1990-11-06 | — | — | US | disclosed |
| EP-0301516-A2 | Dental adhesive composition | MITSUBISHI RAYON CO., LTD. (JP) | 1989-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11597830-B2 | Radiation curable composition for additive manufacturing processes | XRCC6, XRCC5, RAD51 | THRB 1525/4885TSHR 4369/4885ALDH1A1 130/4885 |
| US-20200131356-A1 | RADIATION CURABLE COMPOSITION FOR ADDITIVE MANUFACTURING PROCESSES | XRCC6, XRCC5, RAD51 | THRB 1525/4885TSHR 4369/4885ALDH1A1 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.